Dermatology Times – As an add-on to Mohs surgery, this treatment may have its benefits
Superficial Radio Therapy and our CEO, Joe Sardano, are making headlines with Dermatology Times. This article highlights the benefits of using SRT alongside Mohs surgery when treating skin cancer patients. With 80 percent of skin cancers appearing on the face and neck, a less invasive approach is very sought out by sufferers. Read the full […]
The Dermatologist – Empowering the Patient: Educating Patients on Different Skin Cancer Treatments
It is crucial for dermatologists to be at the frontline of the skin cancer epidemic. Jeffrey S. Fromowitz, MD, FAAD, understands the difficulty educating patients and providing physicians with the different skin cancer treatments that currently are available. Surgery is typically coupled with downtime and invasive procedures. Since many skin cancer treatment recipients are seniors, the […]
2018 Aesthetic Awards: Non-Physician Non-Surgical Innovator of the Year Award
Over the past several years, Mr. Sardano, CEO of Sensus Healthcare, has worked tirelessly to offer a non-surgical solution for non-melanoma skin cancer and an effective treatment for keloid scars. The state-of-the-art Superficial Radio Therapy (SRT) technology is the non-surgical treatment option dermatologists and oncologists have been waiting for. Upon receiving the “Non-Physician Non-Surgical Innovator of […]
CEO Money: Dr Ellen Turner is using a non-invasive, painless method to treat skin cancer
Dr. Ellen Turner discusses with CEO Money host, Michael Yorba, the non-invasive and pain free benefits of treating skin cancer with Superficial Radio Therapy. With Dr. Turner’s two dermatology practice locations in the Dallas area, she knows that one in three Texans will develop skin cancer in their lifetime. Check out the video below or […]
Inc: 19 Ideas on How to Push Yourself to the Next Level
Inc. recently sat down with 19 successful founders and executives to discuss how they push themselves to the next level. When asked about his support system, CEO of Sensus Healthcare, Joe Sardano, said, “One maxim our team hangs onto is, ‘Who packs your parachute?’ This saying comes from an old story originated by a U.S. Navy […]
OWM Industry Spotlight: Joe Sardano
CEO, Chairman and Co-Founder of Sensus Healthcare, Joe Sardano, was recently interviewed for a feature in AAWC‘s research journal, Ostomy Wound Management (OWM). Read the full interview here.
Sensus Healthcare CEO Receives “Innovator of the Year” Award at The Aesthetic Show 2018
BOCA RATON, Fla., July 31, 2018,/PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and keloids with Image-Guided Superficial Radio Therapy (IGSRT), today announced that the Company’s CEO, Joe Sardano, has been named non-physician, nonsurgical “Innovator of the Year” at the 2018 Aesthetic Awards, hosted by The Aesthetic […]
Dr. Kevin Schewe on Colorado’s Best – Non-Surgical Technology for Skin Cancer – Alliance Cancer Care at Red Rocks
Dr. Kevin Schewe the Radiation Oncologist and Medical Director at Alliance Cancer Care at Red Rocks discusses the dangers of UV rays, the different types of skin cancer and SRT with Colorado’s Best on FOX network Channel 2 and Channel 31 in Denver. Watch the video here.
People Magazine – 42-Year-Old Woman Has Survived 86 Skin Cancer Surgeries
Lisa Pace has had 86 skin cancer surgeries and she’s only 42 years old. She was in her 20s when she discovered she had skin cancer after years of using tanning beds. In her interview with People Magazine, she discusses the importance of sun-protection and the dangers of tanning beds. She adds: “I want people to realize that it can […]
WFN1 News – Dermatologist Dr. Ellen Turner on CEO Money
In this week’s CEO Money segment Michael Yorba sits down with Dallas dermatologist, Dr. Ellen Turner to learn about skin cancer, and why her practice is using Superficial Radio Therapy (SRT) — a new, non-surgical skin cancer treatment option that has a remarkable cure rate. Read the full article and listen to the interview here.
